Key Takeaways
- • True Global Ventures nearly doubled its investment position in Prezent through a secondary transaction, signaling continued confidence in the life sciences AI communications platform's execution and growth trajectory.
- • Prezent has achieved 200% annual recurring revenue (ARR) growth year-over-year and serves 150+ life sciences organizations, including 45 leading biopharma companies, with over 5 million completed deliverables.
- • Prezent Vivo launches as an integrated AI plus human expertise platform purpose-built for enterprise communication in life sciences, combining speed, scientific rigor, and cost-effectiveness in a regulated industry context.
- • The investment reflects a broader market thesis that AI value creation increasingly depends on vertical integration of technology, services, and domain-specific intelligence rather than standalone AI tools.
Summary
True Global Ventures announced on April 30, 2026, that it has significantly increased its investment in Prezent through a secondary transaction, nearly doubling its position. The capital deployment underscores TGV's conviction in Prezent's market execution, competitive positioning, and long-term profitable growth prospects.
The announcement coincides with the launch of Prezent Vivo, a new offering that integrates purpose-built artificial intelligence with expert services to deliver enterprise communication solutions specifically designed for the life sciences sector. According to CEO Rajat Mishra, Prezent Vivo enables life sciences companies and their agency partners to obtain speed, scientific rigor, and cost-effectiveness simultaneously—eliminating previous trade-offs between these critical attributes in regulated industries.
Prezent has demonstrated substantial traction ahead of the Vivo launch. The company reported 200% year-over-year ARR growth and currently serves over 150 life sciences organizations, including 45 of the world's leading biopharma companies. The platform has facilitated completion of more than 5 million deliverables across the sector. This operational scale demonstrates established product-market fit and recurring revenue quality within a highly specialized vertical.
Prezent Vivo represents a strategic inflection point for the company, moving beyond standalone AI tooling toward an integrated model combining AI technology with human domain expertise in a single system. The platform is engineered to address the growing demand for outcome-driven solutions in complex, heavily regulated industries where communication directly impacts compliance, efficacy claims, and regulatory approval pathways. TGV's thesis reflects a broader market view that future AI value creation depends on vertical specialization combining intelligence, execution capability, and domain-specific knowledge into cohesive offerings rather than horizontal, generalist AI platforms.
The announcement coincides with the launch of Prezent Vivo, a new offering that integrates purpose-built artificial intelligence with expert services to deliver enterprise communication solutions specifically designed for the life sciences sector. According to CEO Rajat Mishra, Prezent Vivo enables life sciences companies and their agency partners to obtain speed, scientific rigor, and cost-effectiveness simultaneously—eliminating previous trade-offs between these critical attributes in regulated industries.
Prezent has demonstrated substantial traction ahead of the Vivo launch. The company reported 200% year-over-year ARR growth and currently serves over 150 life sciences organizations, including 45 of the world's leading biopharma companies. The platform has facilitated completion of more than 5 million deliverables across the sector. This operational scale demonstrates established product-market fit and recurring revenue quality within a highly specialized vertical.
Prezent Vivo represents a strategic inflection point for the company, moving beyond standalone AI tooling toward an integrated model combining AI technology with human domain expertise in a single system. The platform is engineered to address the growing demand for outcome-driven solutions in complex, heavily regulated industries where communication directly impacts compliance, efficacy claims, and regulatory approval pathways. TGV's thesis reflects a broader market view that future AI value creation depends on vertical specialization combining intelligence, execution capability, and domain-specific knowledge into cohesive offerings rather than horizontal, generalist AI platforms.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.